文献速递前列腺癌

腹膜重建对机器人辅助根治性前列腺切除联合盆腔淋巴结清扫术后淋巴囊肿形成的影响:随机对照试验的系统评价与Meta分析

Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-10-24

该系统评价纳入11项研究共2991例患者,Meta分析纳入5项RCT共1712例。腹膜瓣组淋巴囊肿发生风险显著降低(OR 0.82,95%CI 0.27-1.37,I²=74.54%),症状性淋巴囊肿无显著差异(OR 0.21,95%CI -0.41-0.84,I²=0%)。腹膜瓣术后淋巴囊肿相关并发症、Clavien-Dindo≥3总体并发症及Clavien-Dindo≥3淋巴囊肿相关并发症均显著降低。

要点

  • 腹膜瓣是预防淋巴囊肿最常用的手术技术(9项研究)。
  • 腹膜瓣组淋巴囊肿发生风险显著降低(OR 0.82,95%CI 0.27-1.37,I²=74.54%)。
  • 腹膜瓣组淋巴囊肿相关并发症显著降低(OR 0.36,95%CI 0.04-0.67,I²=0%)。

核心结论

  • 腹膜瓣在机器人辅助根治性前列腺切除联合盆腔淋巴结清扫术后可减少淋巴囊肿形成、淋巴囊肿相关并发症及严重术后不良事件。

研究设计与样本

  • 系统评价纳入11项研究共2991例患者,Meta分析纳入5项随机对照试验共1712例受试者。
  • 检索于2023年8月进行,纳入评估前列腺癌患者行机器人辅助根治性前列腺切除联合盆腔淋巴结清扫并同期行腹膜重建(与或不与其他技术比较)以预防淋巴囊肿形成的研究。
  • 纳入原始前瞻性和回顾性研究,仅随机对照试验进入Meta分析。

主要发现

  • 腹膜瓣是预防淋巴囊肿最常用的手术技术(9项研究)。
  • 腹膜瓣组淋巴囊肿发生风险显著降低(OR 0.82,95%CI 0.27-1.37,I²=74.54%)。
  • 腹膜瓣组症状性淋巴囊肿无显著差异(OR 0.21,95%CI -0.41-0.84,I²=0%)。
  • 腹膜瓣组淋巴囊肿相关并发症显著降低(OR 0.36,95%CI 0.04-0.67,I²=0%)。
  • 腹膜瓣组Clavien-Dindo≥3总体并发症显著降低(OR 0.61,95%CI 0.21-1.0,I²=0%),Clavien-Dindo≥3淋巴囊肿相关并发症显著降低(OR 0.98,95%CI 0.29-1.67,I²=0%)。

关键数值与推荐

  • 淋巴囊肿率:腹膜瓣组OR 0.82(95%CI 0.27-1.37,I²=74.54%)。
  • 症状性淋巴囊肿率:腹膜瓣组OR 0.21(95%CI -0.41-0.84,I²=0%)。
  • 淋巴囊肿相关并发症:腹膜瓣组OR 0.36(95%CI 0.04-0.67,I²=0%)。
  • Clavien-Dindo≥3总体并发症:腹膜瓣组OR 0.61(95%CI 0.21-1.0,I²=0%)。
  • Clavien-Dindo≥3淋巴囊肿相关并发症:腹膜瓣组OR 0.98(95%CI 0.29-1.67,I²=0%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. METHODS: A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. RESULTS: Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I2 = 0%) were significantly lower after PF. CONCLUSIONS: PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Ditonno F, Manfredi C, Franco A, et al. Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2023. PMID: 37875644. doi:10.1038/s41391-023-00744-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。